Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $2,927 | 14 | 48.2% |
| Food and Beverage | $2,875 | 84 | 47.4% |
| Education | $265.44 | 3 | 4.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic, Inc. | $3,639 | 31 | $0 (2023) |
| CVRx, Inc. | $337.33 | 5 | $0 (2024) |
| Abbott Laboratories | $312.50 | 3 | $0 (2020) |
| Boston Scientific Corporation | $275.29 | 6 | $0 (2024) |
| Medtronic Vascular, Inc. | $244.01 | 7 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $232.66 | 11 | $0 (2024) |
| Terumo Medical Corporation | $204.04 | 2 | $0 (2017) |
| Amgen Inc. | $156.70 | 7 | $0 (2024) |
| Impulse Dynamics (USA) Inc. | $137.06 | 2 | $0 (2023) |
| PFIZER INC. | $103.10 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $104.28 | 4 | Boston Scientific Corporation ($35.68) |
| 2023 | $1,496 | 26 | Medtronic, Inc. ($918.98) |
| 2022 | $2,880 | 24 | Medtronic, Inc. ($2,720) |
| 2021 | $94.68 | 2 | Penumbra, Inc. ($73.14) |
| 2020 | $293.30 | 12 | Medtronic Vascular, Inc. ($138.99) |
| 2019 | $206.35 | 3 | Medtronic Vascular, Inc. ($105.02) |
| 2018 | $149.35 | 10 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($43.34) |
| 2017 | $843.64 | 20 | Abbott Laboratories ($289.07) |
All Payment Transactions
101 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/25/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/06/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $34.08 | General |
| Category: Cardiology | ||||||
| 02/28/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $35.68 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 02/20/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $16.74 | General |
| Category: Heart Failure and Hypertension | ||||||
| 11/16/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.92 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/09/2023 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $146.54 | General |
| Category: Heart Failure and Hypertension | ||||||
| 10/22/2023 | Medtronic, Inc. | VENASEAL (Device) | Travel and Lodging | In-kind items and services | $54.00 | General |
| Category: EndoVenous Therapies | ||||||
| 10/22/2023 | Medtronic, Inc. | VENASEAL (Device) | Food and Beverage | In-kind items and services | $49.05 | General |
| Category: EndoVenous Therapies | ||||||
| 10/22/2023 | Medtronic, Inc. | VENASEAL (Device) | Food and Beverage | In-kind items and services | $35.61 | General |
| Category: EndoVenous Therapies | ||||||
| 10/21/2023 | Medtronic, Inc. | VENASEAL (Device) | Food and Beverage | In-kind items and services | $146.77 | General |
| Category: EndoVenous Therapies | ||||||
| 10/21/2023 | Medtronic, Inc. | VENASEAL (Device) | Food and Beverage | In-kind items and services | $61.73 | General |
| Category: EndoVenous Therapies | ||||||
| 10/21/2023 | Medtronic, Inc. | VENASEAL (Device) | Food and Beverage | In-kind items and services | $47.03 | General |
| Category: EndoVenous Therapies | ||||||
| 10/21/2023 | Medtronic, Inc. | VENASEAL (Device) | Food and Beverage | In-kind items and services | $35.75 | General |
| Category: EndoVenous Therapies | ||||||
| 10/21/2023 | Medtronic, Inc. | VENASEAL (Device) | Food and Beverage | In-kind items and services | $33.94 | General |
| Category: EndoVenous Therapies | ||||||
| 10/20/2023 | Medtronic, Inc. | VENASEAL (Device) | Travel and Lodging | In-kind items and services | $378.00 | General |
| Category: EndoVenous Therapies | ||||||
| 10/20/2023 | Medtronic, Inc. | VENASEAL (Device) | Travel and Lodging | In-kind items and services | $56.80 | General |
| Category: EndoVenous Therapies | ||||||
| 09/05/2023 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Education | In-kind items and services | $75.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/09/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/09/2023 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $9.03 | General |
| Category: Heart Failure and Hypertension | ||||||
| 08/02/2023 | Lexicon Pharmaceuticals, Inc. | Inpefa (Drug) | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: Inhibitor of SGLT2 and SGLT1 | ||||||
| 06/28/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: Cardiology | ||||||
| 05/17/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/16/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $17.86 | General |
| Category: Cardiovascular | ||||||
| 05/10/2023 | Impulse Dynamics (USA) Inc. | OPTIMIZER (Device), OPTIMIZER | Food and Beverage | Cash or cash equivalent | $21.40 | General |
| Category: Cardiovascular Device | ||||||
| 05/04/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $16.27 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 2,750 | 5,062 | $911,142 | $307,923 |
| 2022 | 27 | 2,949 | 5,503 | $1.0M | $356,200 |
| 2021 | 33 | 3,243 | 6,151 | $912,091 | $407,200 |
| 2020 | 30 | 3,307 | 6,298 | $577,763 | $410,956 |
All Medicare Procedures & Services
117 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 568 | 1,036 | $225,848 | $87,320 | 38.7% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 174 | 174 | $161,472 | $56,836 | 35.2% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 175 | 350 | $120,148 | $30,902 | 25.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 219 | 220 | $89,760 | $30,038 | 33.5% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 144 | 573 | $92,322 | $25,436 | 27.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 211 | 227 | $34,050 | $15,309 | 45.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 608 | 1,114 | $37,876 | $11,171 | 29.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 71 | 71 | $29,891 | $10,404 | 34.8% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 175 | 175 | $24,675 | $8,309 | 33.7% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 63 | 63 | $24,633 | $8,162 | 33.1% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 61 | 96 | $13,728 | $5,050 | 36.8% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 27 | 152 | $11,856 | $4,025 | 34.0% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 68 | 141 | $9,165 | $3,157 | 34.4% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 76 | 162 | $7,938 | $2,616 | 33.0% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 22 | 166 | $7,470 | $2,441 | 32.7% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Office | 2023 | 23 | 117 | $6,669 | $2,207 | 33.1% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 15 | 15 | $5,730 | $2,154 | 37.6% |
| 33286 | Removal of heart rhythm monitor from under the skin | Office | 2023 | 12 | 12 | $3,324 | $987.70 | 29.7% |
| 85610 | Blood test, clotting time | Office | 2023 | 23 | 179 | $2,744 | $744.63 | 27.1% |
| 93288 | Evaluation of single, dual, multiple lead or leadless pacemaker system | Office | 2023 | 15 | 19 | $1,843 | $653.28 | 35.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 562 | 911 | $198,598 | $80,494 | 40.5% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2022 | 179 | 179 | $166,112 | $61,626 | 37.1% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2022 | 180 | 360 | $123,581 | $32,105 | 26.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 219 | 225 | $91,800 | $30,957 | 33.7% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2022 | 159 | 633 | $101,989 | $30,738 | 30.1% |
About Dr. Thomas Parente, MD
Dr. Thomas Parente, MD is a Cardiovascular Disease healthcare provider based in Tavares, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1093806499.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Parente, MD has received a total of $6,068 in payments from pharmaceutical and medical device companies, with $104.28 received in 2024. These payments were reported across 101 transactions from 19 companies. The most common payment nature is "Travel and Lodging" ($2,927).
As a Medicare-enrolled provider, Parente has provided services to 12,249 Medicare beneficiaries, totaling 23,014 services with total Medicare billing of $1.5M. Data is available for 4 years (2020–2023), covering 117 distinct procedure/service records.
Practice Information
- Specialty Cardiovascular Disease
- Location Tavares, FL
- Active Since 09/28/2006
- Last Updated 06/03/2010
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1093806499
Products in Payments
- ADVISA DR MRI SURESCAN (Device) $2,439
- VENASEAL (Device) $918.98
- Barostim Neo System (Device) $337.33
- AZURE XT DR MRI SURESCAN (Device) $246.29
- Reveal LINQ (Device) $201.74
- SQ-RX PULSE GENERATOR (Device) $184.97
- ICDs (Device) $176.55
- FARXIGA (Drug) $157.66
- Repatha (Biological) $156.70
- Optimizer (Device) $115.66
- Ablation Therapy Hardware (Device) $112.52
- VYNDAQEL (Drug) $103.10
- Optitorque (Device) $102.48
- LifeVest (Device) $92.79
- ENTRESTO (Drug) $77.44
- BRILINTA (Drug) $75.00
- Indigo System (Device) $73.14
- ELIQUIS (Drug) $39.83
- LEXISCAN (Drug) $38.09
- WATCHMAN FLX (Device) $35.68
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Tavares
Dr. Miguel Bryce, Md, MD
Cardiovascular Disease — Payments: $25,115
Dr. Moises Fraifeld, Md, MD
Cardiovascular Disease — Payments: $7,817
Prabhakara Kunamneni, Md, MD
Cardiovascular Disease — Payments: $6,816
Mr. Julio Lesmes, Md, MD
Cardiovascular Disease — Payments: $6,021
Dr. Sammy Gammenthaler, Md, MD
Cardiovascular Disease — Payments: $4,190
Theresa Mills, Md, MD
Cardiovascular Disease — Payments: $4,084